The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Jul. 19, 2022

Filed:

Sep. 26, 2017
Applicant:

Sola Biosciences, Llc, Natick, MA (US);

Inventor:

Akinori Hishiya, Belmont, MA (US);

Assignee:

SOLA BIOSCIENCES, LLC, Natick, MA (US);

Attorneys:
Primary Examiner:
Int. Cl.
CPC ...
C07K 14/00 (2006.01); C12P 21/02 (2006.01); C07K 14/715 (2006.01); C07K 14/755 (2006.01); C07K 16/22 (2006.01); C07K 16/24 (2006.01); C12N 9/64 (2006.01); C07K 16/00 (2006.01); C07K 14/745 (2006.01); C07K 14/705 (2006.01); A61K 48/00 (2006.01);
U.S. Cl.
CPC ...
C12P 21/02 (2013.01); C07K 14/705 (2013.01); C07K 14/70575 (2013.01); C07K 14/7151 (2013.01); C07K 14/7155 (2013.01); C07K 14/745 (2013.01); C07K 14/755 (2013.01); C07K 16/00 (2013.01); C07K 16/22 (2013.01); C07K 16/241 (2013.01); C07K 16/244 (2013.01); C12N 9/644 (2013.01); C12N 9/6437 (2013.01); A61K 48/00 (2013.01); C07K 2317/14 (2013.01); C07K 2317/52 (2013.01); C07K 2319/03 (2013.01); C07K 2319/30 (2013.01); C07K 2319/35 (2013.01); C07K 2319/43 (2013.01); C07K 2319/70 (2013.01); C12N 2710/16622 (2013.01);
Abstract

Cell-associated secretion-enhancing fusion proteins are disclosed that comprise a target protein binding domain and a transmembrane retention domain. Co-expression in a host cell of a fusion protein and a target protein of interest that is temporarily bound by the fusion protein leads to an increased level of target protein secreted from the host cell. The fusion proteins are engineered to be retained with the producing host cell, thus eliminating a non-natural component from the extracellular media of the host cell and simplifying purification of the target protein. Nucleic acid molecules encoding such fusion proteins are also disclosed for use in expressing the fusion proteins in host cells, for use in restoring lost or diminished cell functions, and for use in treating diseases characterized by a lost or diminished cell function. Methods and compositions comprising fusion proteins of the invention are disclosed for use in enhancing the level of co-expressed target proteins secreted from host cells.


Find Patent Forward Citations

Loading…